Next Article in Journal
Ex Vivo and Simulation Comparison of Leakage in End-to-End Versus End-to-Side Anastomosed Porcine Large Intestine
Previous Article in Journal
A Hybrid Deep Learning Framework for Accurate Cell Segmentation in Whole Slide Images Using YOLOv11, StarDist, and SAM2
Previous Article in Special Issue
Electrophysiological Approaches to Understanding Brain–Muscle Interactions During Gait: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms

by
Patricio Cumsille
1,2,*,
Felipe Troncoso
1,†,
Hermes Sandoval
1,3,†,
Jesenia Acurio
1,3 and
Carlos Escudero
1,3,*
1
Vascular Physiology Laboratory, Department of Basic Sciences, Universidad del Bío-Bío, Chillán 3780000, Chile
2
Centre for Biotechnology and Bioengineering (CeBiB), University of Chile, Santiago 8370456, Chile
3
Group of Research and Innovation in Vascular Health (GRIVAS Health), Chillán 3780000, Chile
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Bioengineering 2025, 12(6), 675; https://doi.org/10.3390/bioengineering12060675
Submission received: 16 May 2025 / Revised: 15 June 2025 / Accepted: 18 June 2025 / Published: 19 June 2025
(This article belongs to the Special Issue 10th Anniversary of Bioengineering: Biosignal Processing)

Abstract

Motivated by illuminating the underlying mechanisms of preeclampsia, we develop a changepoint detection-based general and versatile methodology that can be applied to any experimental model, effectively addressing the challenges of high uncertainty produced by experimental interventions, intrinsic high variability, and rapidly and abruptly varying time dynamics in perfusion signals. This methodology provides a systematic and reliable approach for robust perfusion signal analysis. The main innovation of our methodology is a highly efficient automatic data processing system consisting of modular programming components. These components include a signal processing tool for optimal segmentation of perfusion signals by isolating their “genuine” vascular response to experimental interventions, and a novel and suitable normalization to evaluate this response concerning an experimental reference state, typically basal or pre-intervention. In this way, we can identify anomalies in an experimental group compared to a control group by disaggregating noise during the transitions just after experimental interventions. We have successfully applied our general methodology to perfusion signals measured from a preeclampsia-like syndrome model developed by our research group. Our findings revealed impaired brain perfusion in offspring from preeclampsia, particularly dysfunctional brain perfusion signals with inadequate perfusion signal vasoreactivity to thermal physical stimuli. This general methodology represents a significant step towards a systematic, accurate, and reliable approach to robust perfusion signals analysis across various experimental settings with diverse intervention protocols.

1. Introduction

In recent years, advances in imaging technologies have provided real-time responses and continuous brain microcirculation perfusion monitoring during more extended periods. In particular, the laser speckle contrast imaging (LSCI) technique has optimized brain blood flow measurement due to high spatial and temporal resolutions. However, analysis of brain perfusion signals in the in vivo context is quite complex and even harder when analyzing experimental data from animal models for several reasons. The main reason is that brain perfusion measurements have some implicit artifacts occurring during experimentation, such as (1) high intrinsic individual variability of the microcirculation, (2) differences in time frame analysis, and (3) considerable signals’ noise generated by instrumental interventions (mostly manual). Thus, when analyzing brain perfusion, one risks partly disregarding the feasible biological response by not dealing with data uncertainty induced by the significant noise of the signals. In addition, the LSCI technique generates significant amounts of data that require sophisticated analysis techniques, making researchers invest more effort in processing. Therefore, robust methods are crucial to analyzing brain perfusion signals properly.
Regarding brain perfusion measurements, we have progressed in animals from two different conditions using mice exposed to preeclampsia [1]. Preeclampsia (PE) is a human pregnancy hypertension syndrome characterized by reduced placental perfusion and maternal endothelial dysfunction present after 20 weeks of gestation [2,3]. This maternal complication is associated with harmful consequences in the offspring, including a high risk of developing neurological, psychological, or behavioral disorders [4,5,6,7]. We would like to emphasize that research into brain complications and long-term neurodevelopmental outcomes in offspring exposed to PE is still an evolving field. Only a few systematic reviews and meta-analyses have addressed this topic [6,8,9,10]. In [6], it was reported that while the pooled unadjusted estimates did not support a statistically significant association between maternal PE and autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD), the adjusted odds ratios suggested an increased risk, approximately 50% for ASD and 28% for ADHD. These findings contrast with a more recent meta-analysis showing significant associations, indicating a 27% increased risk of ASD and a 29% increased risk of ADHD in offspring exposed in utero to PE [10]. Summarizing, recent meta-analyses report a 27–50% increased risk of ASD and ADHD in children exposed to PE in utero [6,10]. The differences in these studies highlight the evidence’s growth and still-debated nature linking PE to long-term neurodevelopmental disorders. Given the heterogeneity in study designs, diagnostic criteria, and confounder adjustments across studies, further high-quality longitudinal research is required to delineate these associations more precisely.
Preclinical studies in rodents, including pups born from PE-like syndrome (PELS) [11,12], or even clinical studies involving children born to women with PE, have reported impaired brain structural alterations in their children compared with children born to mothers without hypertension in pregnancy [13,14,15,16]. Notably, studying offspring of PELS generated by three different models, we have shown a reduction in the brain angiogenesis process [1] or in the brain microvascular perfusion in a model of PELS generated by administration of the nitric oxide inhibitor, N( ω )-nitro-L-arginine methyl ester (L-NAME) [17]. In addition, impaired brain perfusion seems to be more preferentially present in the female offspring [17,18].
Regarding robust analysis methods, the potential for innovation in optimal changepoint detection-based signal processing applied to brain microvascular blood perfusion analysis is immense. A search for citations of the seminal paper by [19]—which introduced the Pruned Exact Linear Time (PELT) method, which is highly efficient for optimal signal segmentation, refined by “signal processing” and “brain” within all fields—in the Web of Science (WOS) yielded only eight results. To ensure reproducibility, the search was as follows. First, we looked for “Optimal Detection of Changepoints With a Linear Computational Cost” in Journal Citation Reports provided by the WOS. Second, we clicked on this title to view its citations. Third, we refined the citations twice by using the menu “search within all fields” by writing “Signal Processing” followed by “Brain”, regardless of years and keywords. We do not aim to discuss the eight citations here. Still, we limit ourselves to highlighting that this scarcity of works devoted to signal processing for brain perfusion analysis underscores the untapped potential in this area, which should inspire and motivate researchers to make groundbreaking advancements and open new perspectives.
In our previous work [18], which forms part of the eight citations of [19] devoted to signal processing for brain perfusion analysis, we developed a signal processing tool that consisted of optimal segmentation and computation of least-squares piecewise linear approximations (PLAs) for perfusion signals. However, our focus was not on precisely segmenting perfusion signals by disaggregating noise produced by experimental interventions. In this regard, in the present work, we define the times of interest (TOIs) as the times of measurements when the perfusion signal is free of noise produced by experimental interventions. In [18], we did not necessarily disaggregate noise between the TOIs or during the transitions just after experimental interventions. We compared brain blood perfusion signals, measured by an LSCI technique, of a control (or wild type, WT) group and an experimental one, the latter being a reduced uterine perfusion pressure (RUPP) model for PELS. Despite our advances in finding optimal segmentation and making precise calculations of PLAs, we acknowledge some limitations, such as artifacts generated by the administration of physical stimuli. These artifacts induced much noise in perfusion signals, prompting us to improve our methodology to isolate the ”genuine” vascular response to stimuli. It is crucial to systematically address these technical and experimental limitations in brain perfusion analysis, which is critical for reducing imprecision in elucidating fundamental biological questions, thus encouraging advances in the field.
Our overarching goal is to systematize, improve, and generalize our signal processing tool [18] to unravel the “genuine” vascular response, defined as the biological response of the brain’s vasculature to a given experimental intervention, free of the noise produced by the latter. So, the main strength of our general methodology is that it addresses technical and experimental limitations by disaggregating noise between the TOIs. In addition, it is versatile since we can apply it to analyze microvascular blood perfusion signals of any nature without altering the main components of the methodology. These properties make it a valuable tool for a solid quantitative analysis of brain perfusion signals, thereby illuminating, in particular, the complex mechanisms of preeclampsia.

2. Materials and Methods

Our general methodology’s main innovation is a highly efficient automatic data processing system consisting of modular programming components. These components include a signal processing tool for optimal segmentation in TOIs and a novel normalization. These components can isolate the genuine vascular response of perfusion signals to experimental interventions from an experimental reference state, usually basal or pre-intervention. Thus, our general methodology can accurately and reliably compare brain perfusion signals between an experimental and a control group.
The optimal segmentation in TOIs and the novel normalization constitute the main contribution of our general methodology and are described in Section 2.3. They identify the most relevant perfusion signal segments from the experimental and statistical viewpoints, excluding the noise produced by experimental interventions, and removing any systematic biases for accurate and reliable comparison.
The general methodology starts with a data preprocessing step that consists of data collection and formatting following a given experimental model, whose datasets correspond to perfusion signals measured in TOIs determined by the experimenter (yet not optimal), which consist of a basal or pre-intervention state and states after experimental interventions.
In the remainder of this section, we conceptually present the general methodology, the implementation details of which are in Appendix B.

2.1. Data Preprocessing

Data preprocessing is the only step in the general methodology that requires manual intervention from the experimenter and differs according to each experimental model. The experimenter’s role in this step is to conduct an experimental model that involves making perfusion signal measurements in TOIs (a basal or pre-intervention and after experimental interventions). However, from the overall algorithm’s perspective, we strictly limit the experimenter’s role to data collection and transcription, ensuring that we accurately and consistently record the data.
The output of data preprocessing consists of an Excel file prepared by the experimenter. This file contains the raw data used in the subsequent methodology steps. As explained in Appendix B.1, the file is formatted in four columns for every experimental subject.
Once the Excel file is formatted, the first two steps of the general methodology are as follows:
  • Step 1: Read the data preprocessed in the Excel file and convert it into matrices.
  • Step 2: Save the matrices into two data files, one for each group, control and experimental.
In this work, we analyze datasets from a PELS model developed by our research group to illuminate the underlying mechanisms of PE. We refer to Appendix A for details on the experimental model and motivation for the general methodology development. We do not describe the experimental model in the main body of this article since it has already been implemented and published in [1]. In contrast, in this article, we focus on the general methodology and its application to conduct a robust brain perfusion signal analysis to establish an accurate and reliable comparison between two subject groups.

2.2. Automatic Data Processing

It consists of the four stages that follow the first two described in the previous section:
  • Step 3: Format the matrices into as many columns as experimental TOIs.
  • Step 4: Compute the optimal segmentation in TOIs and normalize perfusion signals; Section 2.3 and Appendix B.3.
  • Step 5: Calculate the matrices that one wants to compare.
  • Step 6: Perform the comparative statistical analysis; Appendix B.5.

2.3. Calculation of the Optimal TOIs and Optimal Transitions

Considering experimental TOIs (those determined by the experimenter, not yet optimal), we compute optimal data segmentation in TOIs, which produces two matrices: one that stores the times associated with every TOI, and the second one that stores the transition times between the TOIs. We calculate both matrices for every dataset associated with each experimental subject.
To calculate optimal segmentation in TOIs and transition regions between the TOIs, we considered the “markers” column (the third one of the Excel file), where the experimenter indicated the TOIs each measurement pertains to (basal and after interventions). Of course, the experimenter defined these markers in an ad hoc way, following the experimental protocol. This definition is subject to errors due to implicit artifacts that usually occur during experimentation: (1) high individual variability of the microcirculation, (2) biologically relevant differences in time frame analysis, and (3) artifacts or considerable signal noise (mostly manual) generated by instrumental intervention. Therefore, data segmentation in optimal TOIs is a statistical tool for accurately and reliably comparing each perfusion signal’s response to experimental interventions. In practice, however, the perfusion signal for a given individual cannot be segmented. Perfusion signal segmentation is a mathematical artifact to achieve the work’s comparison goal.
To overcome the issues (1)–(3), we designed the original Algorithm 1. To implement it, we first apply the pure PELT method, i.e., signals’ segmentation without calculating yet optimal TOIs and without disaggregating noise between the TOIs or during the transitions just after experimental interventions. The main output argument of the pure PELT method is a vector containing the positions of changepoints, where the PLA change most significantly for every perfusion signal, denoted by τ R m + 2 ; Appendix B.3. Then, we split τ into n T vectors denoted by τ 1 , , τ n T , where n T stands for the total number of TOIs. Each vector τ j contains the positions of changepoints for every TOI j = 1 , , n T , which we construct by intersecting the “markers” column associated with each dataset collected in the Excel file, with vector B ( τ , 1 ) that contains the times of occurrence of changepoints. Here B is a matrix of size n i × 2 , n i being the number of measurements for experimental subject i, whose columns 1 and 2 store the time points and perfusion values, which we read from the second and fourth columns associated with each studied experimental subject in the Excel file; Appendix B.1.
Considering as input arguments vectors τ , τ 1 , , τ n T , Algorithm 1 reads as follows.
Algorithm 1: Optimal TOIs and transition times.
   1:
Inputs:  τ , τ 1 , , τ n T
   2:
Outputs:  O T O I , O T T
   3:
k length τ 2 , , τ n T = length τ τ 1
   4:
for  j = 1 , , n T do
   5:
     I T j min B ( τ j , 1 )
   6:
    if  j = 1  then
   7:
         O T O I , 1 [ B ( 1 , 1 ) , , I T 2 k 1 ] T
   8:
         O T T , 1 [ I T 2 k , , I T 2 + k ] T
   9:
    else if  j = n T  then
 10:
         O T O I , n T [ I T n T + k + 1 , , B ( n i , 1 ) ] T
 11:
    else
 12:
         O T O I , j [ I T j + k + 1 , , I T j + 1 k 1 ] T
 13:
         O T T , j [ I T j + 1 k , , I T j + 1 + k ] T
 14:
    end if
 15:
end for
The output arguments of Algorithm 1 are two matrices, O T O I and O T T , where O T O I contains the “optimal TOIs” considering noise disaggregation between the TOIs and O T T the “optimal transition times” between the TOIs.
The key of Algorithm 1 is to compute vector I T R n T that contains the experimental “intervention times” defined as the minimum of the times of occurrence of changepoints for every TOI j, as computed by the pure PELT method. Our Algorithm 1 computes the matrix O T O I separately from the matrix O T T that stores the optimal transition times between the optimal TOIs. By doing so, we effectively disaggregate considerable signal noise from instrumental interventions. Consequently, we can compare the genuine response of perfusion signals after their stabilization, focusing solely on their intrinsic variability, not noise produced by interventions during transitions before stabilization.
We remark that the k value assigned in line 3 of Algorithm 1, which we subtract and add from the experimental intervention times (vector I T ) in lines 8 and 13, ensures an accurate and reliable optimal segmentation of perfusion signals. In addition, given that k is defined as the length of the changepoints in the times of interest (TOIs) after experimental interventions or basal TOI, it only depends on when the experimenter applied experimental interventions and not the dataset itself. This makes our general methodology versatile since it applies to any experimental setting.

2.4. Data Normalization

To elucidate whether experimental interventions induce significant changes in perfusion, we normalize perfusion signals concerning a reference state for every experimental subject. To do so, we describe perfusion signals as discrete-time functions representing experimental measurements. Precisely,
y t i , j t i , j 1 + 1 t t i , j
y t i 1 t n i = y t i , j t i , j 1 + 1 t t i , j j = 1 , , n T
Equation (1) represents the perfusion signal in the optimal TOI or segment j, t i , j is the end time for every TOI or segment j, t i , 0 = 0 , (and, respectively, t i , n T = n i ), which corresponds to the first (and, respectively, final) measurement, n i being the number of measurements for experimental subject i. Equation (2) describes the entire perfusion signal for experimental subject i. With these notations, we can introduce a novel z-normalization for every perfusion signal or its PLA associated with each experimental subject i, and every TOI j. This normalization is defined by
z t i , j = y t i , j y i , ref ¯ s i , ref and z ^ t i , j = y ^ t i , j y ^ i , ref ¯ s ^ i , ref .
In Equation (3), we normalize every perfusion signal value y t i , t = 1 , , n i in Equation (2), for every TOI j = 1 , , n T and every experimental subject i = 1 , , N concerning a reference state ‘ref’, usually the basal state j = 1 . The quantities y i , ref ¯ and s i , ref represent the mean and standard deviation of the perfusion signal for the experimental subject i in the reference state. The same explanation is valid replacing y t i for its PLA y ^ t i , t = 1 , , n i , defined in Equation (A3). This way, we can statistically compare perfusion signals after experimental interventions ( j = 2 , , n T ) suitably concerning a basal/reference state ( j = 1 ) among experimental subjects ( i = 1 , , N ), as we show below.
We highlight that any statistical test to compare two or more datasets normalizes every data point concerning its sample mean but not concerning a reference state, as made in the present study. From Equation (3), a simple calculation shows that for every k , = 2 , , n T with k , one has
z t i , k z t i , = y t i , k y t i , s i , ref .
Remark 1. 
Despite the number of measurements in the TOIs k , being generally different, we format the corresponding data segments in a suitable matrix for every experimental subject. This way, we can handle the corresponding data segments for comparison; see Appendix B.2 for details.
Consequently, if k , > 1 are two distinct TOIs after interventions, and z t i , k z t i , is greater than a certain threshold for i fixed, according to Equation (4), this implies that perfusion signal in TOIs or segments j = k and j = defined in Equation (1), have mean and variance significantly different of those given by the reference TOI j = 1 . In other words, perfusion signal segments in experimental states k , > 1 would have significant differences concerning the corresponding basal perfusion signal for experimental subject i. Therefore, with normalization (3), we can establish or deny significantly different responses of perfusion signals to any experimental intervention concerning the basal/reference state. This normalization process is crucial as it could help elucidate anomalies in the perfusion signals’ response to experimental interventions of an experimental group compared to a control one for any experimental model.
From a physiological perspective, driven by the goal of uncovering the underlying mechanisms of PE, our approach can significantly enhance understanding of brain blood perfusion in offspring from normal pregnancies compared with the PELS. This understanding could help tackle the high risk of long-lasting cognitive consequences and stroke in the offspring of PE.

3. Results

In this section, we illustrate the general methodology application to the experimental model data described in Appendix A, addressing the significant research questions that have shaped our approach. In that experimental model, the total number of experimental subjects is N = 33 and the total number of TOIs is n T = 3 . The TOI j = 1 corresponds to the basal state or pre-intervention, the TOI j = 2 to the cold state or after the cool stimulus (first intervention), and the TOI j = 3 to the warm state or after the warm stimulus (second intervention). The experimental subject i = 1 , , 16 belongs to the control or WT group, whereas i = 17 , , N to the experimental or L-NAME group. To clarify notations for the experimental model we analyze here, we follow the general notation (2) to provide some examples. For instance,
y t 16 , 1 t = 1 , , t 16 , 1 y t 23 , 2 t = t 23 , 1 + 1 , , t 23 , 2
z t 16 , 1 t = 1 , , t 16 , 1 z t 23 , 2 t = t 23 , 1 + 1 , , t 23 , 2
Equation (5) designates the perfusion signal segment measured for individual i = 16 (WT male) in the basal state or TOI j = 1 , and the perfusion signal segment for individual i = 23 (L-NAME female) in the cold state or TOI j = 2 , while Equation (6) stands for the corresponding normalized perfusion signal segments according to normalization (3), and so on.
Figure 1 and Figure 2 depict the application of the general methodology to datasets y t i , 1 t n i , defined in Equation (2) for mouse i = 9 (WT male), and mouse i = 17 (L-NAME female), respectively. This application provides a visually compelling comparison, as we plot perfusion signals and their respective PLAs in Figure 1 and Figure 2 on the same scales for the two axes. Precisely, we plot
z t i 1 t n i and z ^ t i 1 t n i ,
which are the normalization computed according to Equation (3) for perfusion signal y t i , 1 t n i and its corresponding PLA y ^ t i , 1 t n i , defined by Equation (A3) and described in Appendix B.3. We plot datasets given in Equation (7) segmented in the optimal TOIs, as denoted by Equation (1). In addition, we plot the optimal transition times between the optimal TOIs, shown in Figure 1 and Figure 2 as segmented vertical lines.
Figure 1 and Figure 2 demonstrate the robustness of our general methodology. The accurate numerical segmentation calculation into the three optimal TOIs, optimal transition times between the TOIs, and the normalized perfusion signal’s PLA corroborate its strength.
Physiologically, we observe basal perfusion with slightly more intrinsic variability for the L-NAME female offspring (in some regions). Importantly, its perfusion signal does not respond to thermal stimuli (Figure 2). On the contrary, the WT male offspring underwent a notorious response to the thermal stimuli, showing an overall drop in perfusion values after the cool stimulus and high intrinsic variability and an overall rise (or recovery concerning its basal state) in perfusion values after the warm stimulus (Figure 1).
The visual comparison in Figure 1 and Figure 2 reveals relevant differences in the perfusion signals of both individuals. In this regard, previous reports have described impaired capacity of brain blood vessels to respond to systemic blood pressure (i.e., autoregulation). Therefore, we would like to know whether these alterations in the middle/large brain blood vessels could also affect brain microcirculation [20,21]. We will quantitatively study this kind of alteration in perfusion signals for the two mouse groups and sexes, as shown in Figure 1 and Figure 2. Indeed, the qualitative result shown in Figure 1 and Figure 2 is a general finding that characterizes perfusion signals for the two mouse groups and sexes. To show that, we apply our general methodology, whose essence is its ability to compare the genuine response of perfusion signals to experimental interventions reliably and accurately. This comparison is reliable since we exclude the optimal transition times between the optimal TOIs (Figure 1 and Figure 2). By doing so, we effectively eliminate considerable signal noise generated by experimental interventions, such as thermal physical stimuli. Consequently, we can compare the genuine response of perfusion signals after their stabilization, focusing solely on their intrinsic variability, not noise produced during transitions. In addition, the comparison is accurate since we quantify the response of perfusion signals to experimental interventions concerning their basal/reference or pre-intervention state, by applying the novel normalization defined in Equation (3).
The rest of this section is organized as follows. In Section 3.1 below, we compare perfusion signals in the basal state, while in Section 3.2 and Section 3.3, we conduct a statistical study to support the result shown in Figure 1 and Figure 2 as a general finding.

3.1. Comparative Statistical Analysis in Basal State

This section compares perfusion signals for experimental subjects and the four interest groups (WT females, WT males, L-NAME females, and L-NAME males) in the basal/reference state. We also compare normalized cold-to-basal and warm-to-cold differences for the four interest groups.
To compare and better visualize, we only once depict the non-normalized basal perfusion signals for experimental subjects in Figure 3. From it, one seems to observe individual variability.
However, the K-W test revealed a p-value of 0.5903 for individuals in Figure 3, indicating no significant differences among non-normalized basal perfusion signals. As one could expect, the normalized basal perfusion, depicted in Figure 4 (the first four bars), does not show significant differences either (K-W test, p = 0.1418 ).
Physiologically, our results suggest that the basal brain perfusion signals do not significantly differ between individuals and the four interest groups.

3.2. Comparative Statistical Analysis for Cold-Induced Response

As explained in Appendix A, in the experimental model developed by our research group, the experimental interventions correspond to thermal physical stimuli (cool and warm) applied to the offspring of mice from two groups: control (WT) and experimental (L-NAME).
Next, we depict the cold-to-basal differences for the normalized perfusion signals, for raw data in Figure 5 and for PLAs in Figure 6. Precisely, both figures show box and whisker plots, one for each experimental subject i = 1 , , N , for the differences z t i , 2 z t i , 1 in Figure 5 and for the differences z ^ t i , 2 z ^ t i , 1 in Figure 6, respectively. Normalization z t i 1 t n i and z ^ t i 1 t n i are defined by Equation (3).
Notably, the normalized values of female and male WT mice showed more dispersion (wider range of values) than female and male L-NAME mice. When we plotted cold-induced perfusion response per group (from the fifth to the eighth bar in Figure 6), WT’s offspring responded significantly differently than L-NAME’s offspring to the cool stimulus.
Our results underscore the importance of our research, indicating that 50% of WT’s offspring, as represented by the median, show an overall drop in the brain perfusion signals after the cool stimulus. This finding is particularly relevant as it is consistent with the case represented by Figure 5 for offspring 9 (WT male, internal code WT14D4). On the other hand, offspring from PE did not respond to the cool stimulus.
Our research confirmed the individual differences in response to the cool stimulus. The K-W test applied to normalized data for the separate individuals depicted in Figure 5 (K-W test, p < 1 × 10 10 ), and the pairwise multi-comparison test applied to the individual cold-to-basal state differences produced the results reported in Table 1, validating the individual differences in response to the cool stimulus.
Table 1 showcases the top 10 individuals with remarkable variations in their cold-induced response. These individuals were selected based on their unique responses compared to at least 27 other subjects we analyzed. Notably, the top six individuals are from the WT group, with five of the six being male.
These results highlight the significant individual differences in response to the cool stimulus, a crucial aspect that piques our interest in this research. Notably, the perfusion signals of mice 9 and 16 (both male WT) stand out as significantly different from all other analyzed mice. We rigorously tested these individual differences to determine whether they were due to specific individuals or the entire interest group. Table 1 reveals that several individuals have significant inter- and intra-group differences, indicating that these differences are not specific to individuals but to the entire interest groups.
Now, we question whether the previous results are due to the high individual variability of raw perfusion signals. Since the PLAs have less variability than raw data, these numerical approximations could indicate a more realistic difference among the individuals studied.
Our preference for the entire PLAs over their slopes or averages, as previously published [18], is rooted in the methodology’s ability to provide optimal segmentation. This segmentation allows for accurate separation in experimental states (i.e., in TOIs) and useful approximations for every perfusion signal, which is valuable for deeper analysis. Even without approximating perfusion signals, our methodology is necessary for accurately separating the TOIs and, thus, precisely quantifying the perfusion vascular response of offspring to both stimuli.
Figure 6 presents box and whisker plots for the normalized PLAs. Despite less variability, Figure 6 shows that PLAs behave qualitatively similarly to the raw cold-to-basal perfusion differences (Figure 5). This analysis confirms that WT offspring undergo an overall diminution, whereas L-NAME offspring show a slight overall increase in brain perfusion to the cool stimulus (Figure 6). We further confirmed these differences by applying the K-W test for the PLAs for individuals depicted in Figure 6. The K-W test for separate individuals yielded p < 1 × 10 10 , indicating a significant difference. It provides strong evidence for the observed differences and reassures the reader of the accuracy of our results.
As expected, the cool stimulus reduced brain perfusion in female and male WT pups. However, offspring from L-NAME-treated dams exhibited no response to the cool stimulus. We did not study the underlying mechanisms responsible for this alteration here. However, previous research showed that offspring from PE have impaired formation [1] and function [21] of brain blood vessels. The present work also indicates alterations also in the microcirculation. This lack of response to cold-induced vasoconstriction in offspring of PE indicates functional alterations that may prompt future cognitive or cerebrovascular diseases. Results also indicate that the male response in each group was exacerbated compared with the female response. Thus, males in the WT group exhibited an increased drop, whereas in the L-NAME group, males exhibited significantly higher brain perfusion than their female siblings. Currently, increasing evidence indicates sex-specific alterations associated with pregnancy complications, including PE [22]. This evidence indicates that males are more susceptible to alterations in the cardio-cerebrovascular or metabolic systems. Our results align with this evidence, indicating that male offspring of PE have brain blood vessels that anomalously respond to cold-induced vasoconstriction. The causes and consequences of this defect require further investigation.

3.3. Comparative Statistical Analysis for Warm-Induced Response

As in our previous analysis, we meticulously and rigorously compared the warm-induced vascular response of normalized perfusion signals depicted in Figure 7 and Figure 8, which represent perfusion signals and their PLAs, respectively, instilling confidence in the thoroughness and reliability of our general methodology.
Our general methodology revealed distinct responses between the WT and L-NAME offspring. When we grouped the data into the four interest groups, the K-W test produced p < 1 × 10 10 (the last four bars in Figure 8). This underscores the significant differences between groups and sexes in each pair comparison.
Our research confirmed the individual differences in response to the warm stimulus. The warm-induced response in the WT group typically led to increased brain perfusion or recovery concerning the basal TOI in most pups, regardless of gender. In contrast, the L-NAME offspring showed no response (Figure 7 and Figure 8). The K-W test applied to normalized data for separate individuals depicted in Figure 7 yielded p < 1 × 10 10 , confirming significant differences between the groups and underlining the importance of our research. These results further confirm alterations in the capacity of the brain microcirculation to detect and/or react to physical thermal stimuli. The physiological or pathophysiological implications of this differential response in offspring from PE require further investigation. However, we know that children born with acute hypoxia, including some infants born to women with PE, are candidates to receive therapeutic hypothermia. Based on our results in this scenario, we could hypothesize that this gold-standard treatment may not have similar outcomes in male and female offspring. However, whether or not this hypothesis is confirmed deserves further investigation.
To further validate our previous findings, we applied the pairwise multi-comparison test to the individual warm-to-cold differences, which we report in Table 2.
Table 2 shows the top nine individuals with remarkable variations in their warm-induced responses. These individuals were selected based on their unique responses compared to at least 27 other subjects we analyzed.
Notably, most mice are from the WT group, where six of them are male. These findings highlight the significant individual differences in response to the warm stimulus, a crucial aspect that deserves our interest. We rigorously tested these individual differences to determine whether they were due to specific individuals or the entire interest group. Table 2 reveals that several individuals have significant inter- and intra-group differences, indicating that these differences are not specific to individuals but to the entire interest groups. Indeed, excluding the three top individuals with significant differences with almost all the rest of the analyzed mice (№9, №16, and №5 in Table 1) did not affect statistical differences. We obtain the same results by analyzing the PLAs depicted in Figure 8.
Our comprehensive research has then provided significant insights into the warm-induced response in mice. It highlights individual variability and significant differences between groups and sexes. These findings underscore the importance and impact of our work in understanding the brain vascular perfusion response to diverse empiric interventions, such as thermal stimuli, in experimental models for PELS.

4. Discussion

Our general methodology, which relies on the PELT method for its high efficiency [19,23], is a reliable and accurate approach for robust brain perfusion signal analysis under various experimental settings. Our main contribution is that we have complemented it with careful data segmentation in optimal TOIs and a novel and suitable data normalization. We specifically looked to improve transition times detection, which motivated us to systematize, generalize, and significantly improve our previous methodology [18]. In addition, the research questions, whose answers are relevant to illuminate the underlying mechanisms of altered brain perfusion signals in L-NAME offspring compared with the uncomplicated WT offspring and the responsiveness of brain perfusion in L-NAME offspring to thermal stimuli, also motivated the enhancement of our methodology.
Our methodology is a step towards a systematic, accurate, and general approach to robust analysis of brain perfusion signals. We could further enhance it by considering other methodologies like those in the reference [24] to handle the transition times. In addition, we could improve our general methodology by incorporating algorithms for allowing multiscale changepoints, which may help us more accurately handle large jumps over short intervals like the transitions between empiric states [25]. Thus, we may extend the general methodology for accurately processing perfusion signals in broad experimental models to elucidate fundamental biological questions, as we did in the present study.
We have extended our previous evidence of reduced brain angiogenesis in the offspring of PELS [1] by demonstrating impaired microvascular reactivity in the brain. Specifically, offspring from L-NAME-treated dams lacked normal cold-induced vasoconstriction and warm-induced vasorecovery with respect to the basal state, indicating vascular dysfunction. We also found sex-specific differences: male WT offspring had a more significant drop in perfusion than females. In contrast, males in the L-NAME group exhibited higher perfusion after cold exposure than females. Individual variability did not affect the observed differences between WT and L-NAME groups or between sexes. Overall, our findings show that PE offspring underwent dysfunctional brain microvascular perfusion with inadequate responses to stimuli, which may lead to neuronal damage, neuroinflammation, and exacerbated hypoxia-induced brain injury.
While our findings suggest impaired vascular responses in offspring from preeclamptic dams, the absence of direct molecular assessment of endothelial dysfunction limits definitive conclusions. Nonetheless, previous studies have reported reduced brain angiogenesis and systemic endothelial alterations in similar models, supporting our interpretation [1,7,14,26,27,28].
Our findings are consistent with previous research showing that male infants born to preeclamptic pregnancies have reduced skin microvascular blood perfusion compared to those from normotensive pregnancies. In contrast, female infants do not show these differences [29]. Additional studies suggest endothelial-dependent vasodilation [30] and maximal capillary density is lower in term infants born to preeclamptic mothers [31]. These findings indicate that infants born to preeclamptic mothers, particularly males and those born at term, may have more pronounced systemic endothelial dysfunction than their counterparts from normotensive pregnancies.
Our study expands on these findings by examining brain microcirculation specifically. We noted a lack of variability in brain perfusion and vascular response to thermal stimuli in the offspring of L-NAME dams, consistent with our earlier reports [17,18]. Although we did not analyze the underlying mechanisms in this study, the alterations may also be associated with endothelial dysfunction, in this case, in the brain. Accordingly, previous studies in different PELS models have shown that offspring exhibit altered brain vasculature, such as smaller and less stiff middle cerebral arteries [20], potentially affecting blood flow autoregulation—the brain’s ability to maintain constant perfusion despite changes in blood pressure.
Sex differences were also evident in our study. Males exhibited more pronounced changes in brain perfusion responses than females, suggesting a sex-specific vulnerability to vascular dysfunction. While females have shown more significant cognitive impairments [32], male infants are often more susceptible to brain complications due to adverse perinatal outcomes, such as severe asphyxia or cerebral palsy [33,34]. Our results align with animal studies demonstrating greater susceptibility to cerebral complications in male offspring from PELS models [35,36]. For example, male offspring from reduced uterine perfusion pressure (RUPP) model dams showed significant brain edema compared to female siblings [17]. In the L-NAME model, we found an atypical response in male offspring: cold stimulus led to vasodilation instead of the expected vasoconstriction observed in males from the WT group or the lack of response seen in female L-NAME pups. This unexpected result suggests that standard treatments, like hypothermic therapy for hypoxic babies, may not be equally effective for both sexes.
In addition, increasing evidence indicates that offspring from PE have long-lasting consequences in brain function. That indicates a higher risk of developing cognitive impairments, including cerebral palsy, impaired neurodevelopment, or a high risk of behavioral alterations during adolescence [7,37]. However, the underlying mechanisms of this epidemiological, clinical, and preclinical evidence are unclear.
Maternal stress hormones, particularly elevated cortisol, have been implicated in fetal neurodevelopmental programming and may confound cerebrovascular outcomes in offspring [38,39]. While studies on maternal stress and cardiovascular programming exist, evidence directly linking maternal stress to cerebrovascular alterations in offspring remains scarce and warrants further investigation [40].

5. Conclusions

Our general methodology is a significant step towards a systematic, accurate, and reliable approach to robust brain perfusion signal analysis under various conditions and experimental settings. The results of the methodology reveal impaired brain perfusion in the offspring of preeclamptic pregnancies, underscoring the urgent need to better understand the underlying mechanisms. Altered brain vascular function may affect brain development in these children [15], suggesting that future research should focus on the sex-specific impacts of PE and endothelial dysfunction. This emphasis on sex-specific research could lead to more targeted interventions.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/bioengineering12060675/s1.

Author Contributions

P.C.: Conceptualization (of the overall numerical algorithm and scripts), methodology, software, validation, formal analysis (of statistical results), investigation, data curation, writing—original draft, writing—review and editing. F.T. and H.S.: Methodology (performed all the in vivo experiments). J.A.: Writing—original draft and supervision (monitoring the progress of experimental work). C.E.: Conceptualization (of experimental protocol), formal analysis (biomedical interpretation of results), writing—original draft, writing—reviewing and editing, project administration, funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This study was funded by Fondecyt projects, numbers 1240295 and 1200250, the Centre for Biotechnology and Bioengineering (CeBiB) under grant AFB240001 from the ANID, Chile, and the internal project VRIP-UBB GI2301146.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets studied in the work are included in the Supplementary Material. The corresponding authors can be contacted for further inquiries.

Acknowledgments

The authors thank the Vascular Physiology Laboratory and GRIVAS Health researchers for their valuable input.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
TOI(s)Time(s) of interest (based on experimental interventions)
PEPreeclampsia
LSCILaser speckle contrast imaging
PELSPE-like syndrome
PELTPruned exact linear time
WOSWeb of Science
PLAsLeast-squares piecewise linear approximations
WTWild type
RUPPReduced uterine perfusion pressure
L-NAMEN( ω )-nitro-L-arginine methyl ester
K-W testKruskal–Wallis test

Appendix A. Experimental Model and Motivation

This section is devoted to describing the experimental model, which involves a specific control and experimental group, the number of subjects in each group to conduct an experimental protocol, a summary of the main results obtained by our research group, and the original research questions that motivated us to significantly enhance our methodology.
Our research group implemented an experimental model involving 16 offspring in a control group and 17 offspring in a PELS model [1]; in total N = 33 datasets. The control group, not exposed to the PELS-inducing factor, serves as a baseline for comparison. The control group is a critical component of our research design as it allows us to isolate the effects of the PELS-inducing factor and observe the specific changes in the PELS model. As detailed in the cited reference, this meticulous implementation focused on reproducing a PELS model by delivering L-NAME, a non-selective nitric oxide synthase inhibitor, in drinking water to induce PELS in WT mice.
Figure A1 depicts a scheme of the experimental protocol conducted in [1], where a detailed description and characterization of the used animal model of preeclampsia was published.
Figure A1. Experimental protocol. (A) Representative cartoon of the LSCI technique. (B) Representative brain perfusion image at basal state and after a cool and warm stimulus.
Figure A1. Experimental protocol. (A) Representative cartoon of the LSCI technique. (B) Representative brain perfusion image at basal state and after a cool and warm stimulus.
Bioengineering 12 00675 g0a1
The Bioethics and Biosafety Committee of the Universidad del Bío-Bío approved the animal management and supervision protocols used in this study in agreement with the 3R principles referring to the humane use of animals. All experiments are reported following the ARRIVE guidelines 2.0. Female and male C57BL/6 mice were housed in a 25 °C temperature and humidity-controlled room in the Vivarium belonging to Universidad del Bío-Bío. Inbred strains of mice obtained in our animal facility were used for all experiments. Light–dark cycles were 12:12 h, and mice were fed balanced food (Prolab RMH 3000, Labdiet, St. Louis, MI, USA) and water ad libitum [17,18]. Female mice were cross-bred at 3–5 months with C57BL/6 male mice of similar age. The presence of a vaginal plug was designated as gestational day 0 (D0). For generating PELS, wild-type C57BL/6 pregnant mice were supplemented in drinking water with the nitric oxide synthase inhibitor, NG-Nitroarginine methyl ester hydrochloride, L-NAME (150 mg/kg/d) since D7 of gestation, as previously described, with minor modifications. Pregnant mice were sacrificed at gestational day 19 (D19) for PELS characterization, including a significant increase in the systemic blood pressure; kidney structural and functional (proteinuria) alterations; evidence of placental alterations, including decreased placental efficiency; and increased markers of systemic endothelial dysfunction [1]. We included 16 pups at postnatal day 5 (P5) in the control group (wild type, WT, five females, and 11 males) and 17 pups (P5) in the PELS model (L-NAME, ten females, and seven males).
Our veterinary staff performed the selection based on the number of pups per litter and ongoing experimental needs, without knowledge of downstream analyses. To ensure blinding, all selected pups were coded, and the investigator performing the brain perfusion measurements was blinded to both the experimental group and the sex of the animals.
In vivo, cerebral perfusion analysis in mice pups (P5) was performed using the Pericam©PSI-HR system (Perimed Ltd., Stockholm, Sweden) as described previously [17,18]; see Figure A1, which depicts the experimental protocol. Briefly, the experimental protocol consisted of basal perfusion analysis (3–4 min), followed by cold-induced vasoconstriction (direct application of cold saline solution, 0.9 NaCl w/v, 4 ºC), and ended with warm-induced vasorecovery (direct application of warm saline solution, 0.9% NaCl, w/v, 37 ºC) on the exposed brain. Perfusion was continuously recorded during the whole experiment (approximately 10 min). Experiments were performed head-to-head, including pups from the two experimental groups. At the same time, we performed raw data analysis in a sex-blind manner.
Remark A1. 
This process allowed us to generate the TOIs or experimental states, basal, cold, and warm, for which we wanted to observe the responsiveness of brain blood perfusion, an essential aspect of our research.
The previous work led the authors to conclude that offspring from PELS (L-NAME) have less angiogenic capacity, leading to a significant reduction in blood vessels in the brain cortex, which is a profound and novel finding [1]. This discovery raises important questions about the altered brain blood perfusion in L-NAME offspring compared with the uncomplicated WT offspring and the responsiveness of brain blood perfusion in L-NAME offspring to thermal stimuli. These questions, which could have significant implications in biomedical research, led us to enhance our previous methodology [18] and apply it to try to answer them.

Appendix B. General Methodology Implementation

We have implemented all the modular programming components’ codes in MATLAB R2022b.

Appendix B.1. Data Preprocessing

In this section, we explain the implementation of steps 1 and 2 of Section 2.1.
The Excel file is formatted in four columns for every experimental subject: one that indicates the number of total measurements (in a single cell), another that stores the time points (in milliseconds) where the experimenter took measurements, another indicating the markers, i.e., to what TOI each measurement pertains (basal or pre-intervention state and after experimental interventions), and the last for recording the perfusion value in every time point.
In step 1, we leveraged the MATLAB command readmatrix that allowed us to read and convert the datasets previously saved in the Excel file into matrices. This command facilitated the storage of one matrix for each of the N experimental subjects. Each matrix B, of n i × 2 , contains the time points in column 1 and the perfusion values in column 2, with n i representing the number of perfusion measurements for every experimental subject i = 1 , , N .
Remark A2. 
In the animal model in [1], we have N = 33 brain perfusion signals measured in three TOIs, basal state, cold state (after cool stimulus), and warm state (after warm stimulus), for 16 WT and 17 L-NAME mice; see Appendix A.
In step 2, we stored every matrix ordered according to the experimental subjects’ numeration and assigned an identifier (an integer) accordingly. It includes saving the indices of the time points where the experimenter applied experimental interventions (e.g., cold and warm stimuli). These indices, which indicate the specific time points of the interventions, are crucial for tracking and analyzing their effects. Though not automatic, this step is a crucial part of the process, ensuring the data processing system operates precisely. However, we made it only once and automatically conducted all subsequent steps using the identifiers and their associated stored matrices.

Appendix B.2. Data Processing

In step 3, we formatted the matrices into as many columns as experimental TOIs, n T ( n T = 3 in the experimental model explained in Appendix A; basal, cold, and warm states). We fill each missing data point with a NaN (“Not a Number”) since the measurements in each TOI are not the same size.
Step 4 constitutes the main contribution of our general methodology. Using the identifier of each dataset, we efficiently and automatically implemented step 4 through the following stages:
  • Apply the signal processing tool to raw datasets after data preprocessing; see Appendix B.3.
  • Normalize perfusion signals (raw datasets) and their PLAs, compute optimal segmentation in TOIs, and normalize again; see Section 2.3.
  • Apply the signal processing tool to normalized datasets; see Appendix B.3.
In step 5, we calculated the matrices one might want to compare. For instance, if one wants to compare the cold response concerning the basal state, we computed a matrix of n × N , where n = max { n i : i = 1 , , N } stands for the maximum number of measurements between all the experimental subjects. Each row i of the matrix contains the normalized cold-to-basal perfusion signal differences z t i , 2 z t i , 1 , computed according to (3), crucial for the comparative statistical analysis in the next step. We also calculated the corresponding PLAs for the normalized cold-to-basal differences z ^ t i , 2 z ^ t i , 1 , the warm-to-cold differences z t i , 3 z t i , 2 and their corresponding PLAs z ^ t i , 3 z ^ t i , 2 for comparison. For details on the novel normalization we define in Equation (3), see Section 2.4.
In step 6, we compared responses to the experimental interventions of the normalized perfusion signals for every experimental subject. This step is crucial as it allows us to compare responses in the cold and warm states, normalized with respect to the basal state, which translates into comparing the columns of the matrices computed in step 5, where each column represents a distinct sample of the same variable. In this case, the variable is the normalized cold-to-basal or warm-to-cold perfusion signal differences as explained above. The different groups for sampling this variable correspond to every experimental subject (in this case, there are N = 33 groups).

Appendix B.3. Signal Processing Tool

In our previous work [18], we implemented a signal processing tool that produces optimal data segmentation according to the experimental states without disaggregating noise between TOIs or during the transitions just after experimental interventions. For completeness, since we did not provide a complete description of the signal processing tool in the cited reference, we do so in this section.
The optimal data segmentation we apply relies on the PELT method introduced by Killick et al. (2012) [19]. The main idea is to find the positions where a cost function, which measures the goodness of fit of a chosen statistical property, changes most significantly for a data sequence. A dataset contains a changepoint if we can split it into two segments such that the sum of the cost function at each data piece is less than the overall cost function. For example, the cost function for detecting changepoints in the mean is the sum of the residual squared error for every segment from its local mean [41]. In general, this approach identifies multiple changepoints by minimizing the overall cost function defined as the sum of the cost function between two consecutive changepoints, i.e., the goodness of fit criterion of the statistical property to data within each segment. In addition, the PELT method adds a penalization term to avoid overfitting, which is produced by continuously decreasing the goodness of fit criterion by adding new changepoints into the algorithm.
Formally, let y 1 : n = ( y 1 , , y n ) be a data sequence with n data points. The PELT method provides the positions of changepoints τ 1 : m = τ 1 , , τ m , where 1 τ i n 1 inclusive. Defining τ 0 = 0 , τ m + 1 = n and assuming that the changepoints are ordered, i.e., τ i < τ j for every i < j , the m changepoints will split the data into m + 1 segments, where the ith segment corresponds to y τ i 1 + 1 : τ i for i = 1 , , m + 1 . To identify multiple changepoints, one must minimize the global cost function:
i = 1 m + 1 C y τ i 1 + 1 : τ i + β f ( m ) .
In the equation above, C y τ i 1 + 1 : τ i is the cost function for the ith segment, β f ( m ) is a penalty term to avoid overfitting, and β > 0 is a constant independent on the number or location of changepoints (in practice, usually f ( m ) = m ).
In the present work, the chosen cost function is the piecewise least-squares linear approximations (PLAs) of data segments, equivalent to assuming that every data segment is normally distributed, whose mean corresponds to a piecewise linear model. Then, the cost function of each segment is the error sum of squares between the data and the least-squares regression straight line that fits them within each piece, where the parameters of the straight line are the intercept and slope. Precisely, the segment cost function C in Equation (A1) is defined by
C y τ i 1 + 1 : τ i = min θ i 1 , θ i 2 t = τ i 1 + 1 τ i y t θ i 1 t θ i 2 2 ,
where θ i 1 and θ i 2 are the intercept and slope of the least-squares regression straight line that fits the signal in the ith segment. Therefore, the optimal solution consists of the positions of changepoints τ 0 : m + 1 , and the PLA for the ith segment y τ i 1 + 1 : τ i , given by
y ^ t = θ ^ i 1 + t θ ^ i 2 for every i = 1 , , m + 1 , and t ,
where t corresponds to any time point between the positions τ i 1 + 1 and τ i inclusive, and θ ^ i j is the least-squares estimate of θ i j within the ith data segment.

Implementation

We applied the MATLAB’s subroutine ischange [41], whose main input argument B is a matrix containing columns 2 and 4 of the Excel file in the data preprocessing; Section 2.1. Matrix B is of size n i × 2 , whose columns 1 and 2 store the time points and the perfusion values for every measurement that the experimenter took, where n i is the number of measurements for each perfusion signal i ( n i varies between 750 and 2750). In addition, we select the linear method to find the most significant changepoints in the slope of the PLA for every data segment. Finally, we set the MaxNumChanges option to ten to avoid overfitting and detect the essential changepoints, which, according to the experimental interventions described in Appendix A [1], should be at least three.
The output arguments of the MATLAB’s ischange subroutine are the vector τ that stores the positions of the time points where the most significant changepoints in slopes occur (vector τ 0 : m + 1 ), and the vectors θ 1 ^ and θ 2 ^ that store the intercepts and slopes of the PLA, respectively. Thus, one can construct the PLA, which approximates the perfusion signal values stored in B ( , 2 ) by
y t ^ = θ 1 ^ + t θ 2 ^ ,
where t is any time point between the positions τ j 1 + 1 and τ j , stored in B ( i , 1 ) for every i = τ j 1 + 1 , , τ j and i = 1 , , m + 1 .

Appendix B.4. Optimal Calculation of the TOIs and Transition Times

We calculate optimal data segmentation in two matrices O T O I of size m T × n T and O T T of size m T × ( n T 1 ) . Every column j of O T O I corresponds to the optimal TOI j = 1 , , n T , while every column j of O T T corresponds to the optimal transition times between the TOIs j and j + 1 for every j = 1 , , n T 1 . In addition, O T O I s i , j (respectively, O T T s i , j ) corresponds to the measurement i in the optimal TOI j (respectively, in the optimal transition times between the TOIs j and j + 1 ) for every i = 1 , , m T , where m T is the maximum number of measurements among all the optimal TOIs. When m T is greater than the number of measurements for a given T O I j, then we fill the missing data points with a NaN.
In the case of the experimental model conducted in [1] and briefly explained in Appendix A, the authors measured perfusion signals in states: basal or pre-intervention, cold (after applying a cold stimulus), and warm (after applying a warm stimulus). Thus, we have n T = 3 optimal TOIs for the basal or pre-intervention state and the states after applying the cold and warm stimulus. Similarly, we have n T 1 = 2 optimal transition times between the TOIs basal and cold, and between cold and warm.
We calculate the minimum of the cold TOI when the signal processing tool detects the first abrupt slope change in the PLA after applying the cold stimulus, precisely when the basal state finishes. Similarly, we calculate the minimum of the warm TOI when the signal processing tool detects the first abrupt slope change in the PLA after applying the warm stimulus, precisely when the cold state finishes. Thus, we accurately obtain optimal segmentation into the basal, cold, and warm TOIs by computing the PLA for every perfusion signal, which is part of the tasks of the signal processing tool described in the previous section.

Appendix B.5. Comparative Statistical Analysis

We conducted a qualitative and quantitative statistical comparison of the normalized perfusion signals for the two groups and sexes for separate individuals. We also pooled them together in the four groups of interest (WT females and males and L-NAME females and males). Precisely, we compared z t i , j z t i , 1 and their PLA z ^ t i , j z ^ t i , 1 for every j = 2 , , n T between the experimental subjects i = 1 , , N and pooling these statistics per groups of interest, where we computed z t i , j and z ^ t i , j by (3).
We employed a variety of statistical analysis tools to conduct the statistical comparisons between the control and experimental groups and sexes, which we explain below.
We plotted normalized perfusion signals and their respective PLA to qualitatively illustrate optimal segmentation in TOIs and transition time windows between TOIs, and we compared brain perfusion for two selected experimental subjects. In addition, we depicted processed datasets as box and whisker plots, where every box displays the interquartile range (the box’s limits are the 25th and 75th percentiles of the distribution), the median (a red line within the box), the whisker displays the minimum and maximum values of the distribution (depicted as the whisker’s limits), and the outliers (beyond the whisker’s limits marked with crosses). The plotted datasets correspond to the perfusion signals for every separate experimental subject and four interest groups: control (WT) females and males, and experimental (L-NAME) females and males.
We analyzed the differences between the raw data and the PLA for every experimental subject by separating the analysis by individuals and the four interest groups. We employed the Kruskal–Wallis (K-W) test to verify or deny the statistical significance of the differences. It is worth noting that the K-W test is a nonparametric version of the one-way ANOVA test. Thus, we did not test whether our datasets came from a given reference probability distribution. In addition, to deepen the comparison analysis, we studied the individuals’ differences in their responses to experimental interventions (thermal stimuli) to verify whether these were due to specific individuals or the entire interest group. To do so, we employed a multi-comparison test based upon Tukey’s honestly significant difference procedure to determine if the mean pairwise differences were significantly different. We considered a p-value less than 0.05 as statistically significant. We remark that the built-in MATLAB function that implements Tukey’s honestly significant difference test, by default, uses the Tukey–Kramer correction to adjust the critical value to ensure that the data’s overall distribution error rate is controlled. This means the probability of making one Type I error across all comparisons is kept under the desired level of 0.05 .

References

  1. Troncoso, F.; Sandoval, H.; Ibañez, B.; López-Espíndola, D.; Bustos, F.; Tapia, J.C.; Sandaña, P.; Escudero-Guevara, E.; Nualart, F.; Ramírez, E.; et al. Reduced Brain Cortex Angiogenesis in the Offspring of the Preeclampsia-Like Syndrome. Hypertension 2023, 80, 2559–2571. [Google Scholar] [CrossRef] [PubMed]
  2. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy: Executive Summary. Obstet. Gynecol. 2013, 122, 1122–1131. [CrossRef]
  3. American College of Obstetricians and Gynecologists: ACOG Practice Bulletin 222. Gestational Hypertension and Preeclampsia. Obstet. Gynecol. 2020, 135, e237–e260. [CrossRef] [PubMed]
  4. Figueiró-Filho, E.A.; Croy, B.A.; Reynolds, J.N.; Dang, F.; Piro, D.; Rätsep, M.T.; Forkert, N.D.; Paolozza, A.; Smith, G.N.; Stroman, P.W. Diffusion Tensor Imaging of White Matter in Children Born from Preeclamptic Gestations. Am. J. Neuroradiol. 2017, 38, 801–806. [Google Scholar] [CrossRef]
  5. Figueiró-Filho, E.A.; Mak, L.E.; Reynolds, J.N.; Stroman, P.W.; Smith, G.N.; Forkert, N.D.; Paolozza, A.; Rätsep, M.T.; Croy, B.A. Neurological function in children born to preeclamptic and hypertensive mothers—A systematic review. Pregnancy Hypertens. 2017, 10, 1–6. [Google Scholar] [CrossRef]
  6. Maher, G.M.; O’Keeffe, G.W.; Kearney, P.M.; Kenny, L.C.; Dinan, T.G.; Mattsson, M.; Khashan, A.S. Association of Hypertensive Disorders of Pregnancy with Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis. JAMA Psychiatry 2018, 75, 809–819. [Google Scholar] [CrossRef] [PubMed]
  7. Escudero, C.; Kupka, E.; Ibañez, B.; Sandoval, H.; Troncoso, F.; Wikström, A.K.; López-Espíndola, D.; Acurio, J.; Torres-Vergara, P.; Bergman, L. Brain Vascular Dysfunction in Mothers and Their Children Exposed to Preeclampsia. Hypertension 2023, 80, 242–256. [Google Scholar] [CrossRef]
  8. Dachew, B.A.; Mamun, A.; Maravilla, J.C.; Alati, R. Pre-eclampsia and the risk of autism-spectrum disorder in offspring: Meta-analysis. Br. J. Psychiatry 2018, 212, 142–147. [Google Scholar] [CrossRef]
  9. Jenabi, E.; Karami, M.; Khazaei, S.; Bashirian, S. The association between preeclampsia and autism spectrum disorders among children: A meta-analysis. Korean J. Pediatr. 2019, 62, 126–130. [Google Scholar] [CrossRef]
  10. Zhen Lim, T.X.; Pickering, T.A.; Lee, R.H.; Hauptman, I.; Wilson, M.L. Hypertensive disorders of pregnancy and occurrence of ADHD, ASD, and epilepsy in the child: A meta-analysis. Pregnancy Hypertens. 2023, 33, 22–29. [Google Scholar] [CrossRef]
  11. Liu, X.; Zhao, W.; Liu, H.; Kang, Y.; Ye, C.; Gu, W.; Hu, R.; Li, X. Developmental and Functional Brain Impairment in Offspring from Preeclampsia-Like Rats. Mol. Neurobiol. 2016, 53, 1009–1019. [Google Scholar] [CrossRef] [PubMed]
  12. Tachibana, R.; Umekawa, T.; Yoshikawa, K.e.a. Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions. Sci. Rep. 2019, 9, 234. [Google Scholar] [CrossRef]
  13. Catarino, C.; Rebelo, I.; Belo, L.; Rocha, S.; Castro, E.B.; Patrício, B.; Quintanilha, A.; Santos-Silva, A. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Growth Factors 2009, 27, 345–351. [Google Scholar] [CrossRef]
  14. Kvehaugen, A.S.; Dechend, R.; Ramstad, H.B.; Troisi, R.; Fugelseth, D.; Staff, A.C. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 2011, 58, 63–69. [Google Scholar] [CrossRef] [PubMed]
  15. Rätsep, M.T.; Paolozza, A.; Hickman, A.F.; Maser, B.; Kay, V.R.; Mohammad, S.; Pudwell, J.; Smith, G.N.; Brien, D.; Stroman, P.W.; et al. Brain Structural and Vascular Anatomy Is Altered in Offspring of Pre-Eclamptic Pregnancies: A Pilot Study. Am. J. Neuroradiol. 2016, 37, 939–945. [Google Scholar] [CrossRef]
  16. Yu, G.Z.; Aye, C.Y.; Lewandowski, A.J.; Davis, E.F.; Khoo, C.P.; Newton, L.; Yang, C.T.; Al Haj Zen, A.; Simpson, L.J.; O’Brien, K.; et al. Association of Maternal Antiangiogenic Profile at Birth with Early Postnatal Loss of Microvascular Density in Offspring of Hypertensive Pregnancies. Hypertension 2016, 68, 749–759. [Google Scholar] [CrossRef] [PubMed]
  17. Lara, E.; Rivera, N.; González-Bernal, A.; Rojas, D.; López-Espíndola, D.; Rodríguez, A.; Escudero, C. Abnormal cerebral microvascular perfusion and reactivity in female offspring of reduced uterine perfusion pressure (RUPP) mice model. J. Cereb. Blood Flow Metab. 2022, 42, 2318–2332. [Google Scholar] [CrossRef]
  18. Cumsille, P.; Lara, E.; Verdugo-Hernández, P.; Acurio, J.; Escudero, C. A robust quantitative approach for laser speckle contrast imaging perfusion analysis revealed anomalies in the brain blood flow in offspring mice of preeclampsia. Microvasc. Res. 2022, 144, 104418. [Google Scholar] [CrossRef]
  19. Killick, R.; Fearnhead, P.; Eckley, I.A. Optimal Detection of Changepoints with a Linear Computational Cost. J. Am. Stat. Assoc. 2012, 107, 1590–1598. [Google Scholar] [CrossRef]
  20. Whitaker, E.E.; Johnson, A.C.; Miller, J.E.; Lindner, D.P.; Cipolla, M.J. Abnormal development of cerebral arteries and veins in offspring of experimentally preeclamptic rats: Potential role in perinatal stroke. Mech. Ageing Dev. 2021, 196, 111491. [Google Scholar] [CrossRef]
  21. Whitaker, E.E.; Johnson, A.C.; Tremble, S.M.; McGinn, C.; DeLance, N.; Cipolla, M.J. Cerebral Blood Flow Autoregulation in Offspring From Experimentally Preeclamptic Rats and the Effect of Age. Front. Physiol. 2022, 13, 924908. [Google Scholar] [CrossRef] [PubMed]
  22. Campbell, N.; Solise, D.; Deer, E.; LaMarca, B. Sex differences in offspring of preeclamptic pregnancies. Curr. Opin. Physiol. 2023, 34, 100688. [Google Scholar] [CrossRef] [PubMed]
  23. Cho, H.; Kirch, C. Data segmentation algorithms: Univariate mean change and beyond. Econom. Stat. 2024, 30, 76–95. [Google Scholar] [CrossRef]
  24. Dev, R.; Kumar, S.; Gandhi, T.K. Detecting Microstate Transition in Human Brain via Eigenspace of Spatiotemporal Graph. IEEE Sens. Lett. 2023, 7, 7002004. [Google Scholar] [CrossRef]
  25. Cho, H.; Kirch, C. Two-stage data segmentation permitting multiscale change points, heavy tails and dependence. Ann. Inst. Stat. Math. 2022, 74, 653–684. [Google Scholar] [CrossRef]
  26. Brodowski, L.; Burlakov, J.; Hass, S.; von Kaisenberg, C.; von Versen-Höynck, F. Impaired functional capacity of fetal endothelial cells in preeclampsia. PLoS ONE 2017, 12, e0178340. [Google Scholar] [CrossRef]
  27. Giachini, F.R.; Galaviz-Hernandez, C.; Damiano, A.E.; Viana, M.; Cadavid, A.; Asturizaga, P.; Teran, E.; Clapes, S.; Alcala, M.; Bueno, J.; et al. Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries. Hypertens. Rep. 2017, 19, 83. [Google Scholar] [CrossRef]
  28. Jayet, P.Y.; Rimoldi, S.F.; Stuber, T.; Salmòn, C.S.; Hutter, D.; Rexhaj, E.; Thalmann, S.; Schwab, M.; Turini, P.; Sartori-Cucchia, C.; et al. Pulmonary and Systemic Vascular Dysfunction in Young Offspring of Mothers with Preeclampsia. Circulation 2010, 122, 488–494. [Google Scholar] [CrossRef]
  29. Stark, M.J.; Clifton, V.L.; Wright, I.M. Neonates Born to Mothers with Preeclampsia Exhibit Sex-Specific Alterations in Microvascular Function. Pediatr. Res. 2009, 65, 291–295. [Google Scholar] [CrossRef]
  30. Touwslager, R.N.H.; Houben, A.J.H.M.; Gielen, M.; Zeegers, M.P.; Stehouwer, C.D.A.; Zimmermann, L.J.; Kessels, A.G.H.; Gerver, W.M.; Blanco, C.E.; Mulder, A.L.M. Endothelial vasodilatation in newborns is related to body size and maternal hypertension. J. Hypertens. 2012, 30, 124–131. [Google Scholar] [CrossRef]
  31. Antonios, T.F.; Raghuraman, R.P.; D’Souza, R.; Nathan, P.; Wang, D.; Manyonda, I.T. Capillary remodeling in infants born to hypertensive pregnancy: Pilot study. Am. J. Hypertens. 2012, 25, 848–853. [Google Scholar] [CrossRef] [PubMed]
  32. Taylor, B.D.; Ness, R.B.; Klebanoff, M.A.; Tang, G.; Roberts, J.M.; Hougaard, D.M.; Skogstrand, K.; Haggerty, C.L. The impact of female fetal sex on preeclampsia and the maternal immune milieu. Pregnancy Hypertens. 2018, 12, 53–57. [Google Scholar] [CrossRef]
  33. Mohamed, M.; Aly, H. Impact of race on male predisposition to birth asphyxia. J. Perinatol. 2014, 34, 449–452. [Google Scholar] [CrossRef] [PubMed]
  34. Cans, C. Surveillance of cerebral palsy in Europe: A collaboration of cerebral palsy surveys and registers. Dev. Med. Child Neurol. 2000, 42, 816–824. [Google Scholar] [CrossRef]
  35. Carver, A.R.; Andrikopoulou, M.; Lei, J.; Tamayo, E.; Gamble, P.; Hou, Z.; Zhang, J.; Mori, S.; Saade, G.R.; Costantine, M.M.; et al. Maternal Pravastatin Prevents Altered Fetal Brain Development in a Preeclamptic CD-1 Mouse Model. PLoS ONE 2014, 9, e0100873. [Google Scholar] [CrossRef]
  36. Hofsink, N.; Dijkstra, D.J.; Stojanovska, V.; Scherjon, S.A.; Plösch, T. Preeclampsia-induced alterations in brain and liver gene expression and DNA methylation patterns in fetal mice. J. Dev. Orig. Health Dis. 2023, 14, 146–151. [Google Scholar] [CrossRef]
  37. Zhang, H.; Lin, J.; Zhao, H. Impacts of Maternal Preeclampsia Exposure on Offspring Neuronal Development: Recent Insights and Interventional Approaches. Int. J. Mol. Sci. 2024, 25, 11062. [Google Scholar] [CrossRef]
  38. Anna, K.R.; Sara, S.; Hidalgo, A.P.C.; Kelly M., B.; Elisabeth B., B.; Megan Loraine, C.; Doretta, C.; Charlotte, A.M.C.; Elena, C.; Cristiana, C.; et al. Epigenome-wide meta-analysis of prenatal maternal stressful life events and newborn DNA methylation. Mol. Psychiatry 2023, 28, 5090–5100. [Google Scholar] [CrossRef]
  39. Tartour, A.I.; Chivese, T.; Eltayeb, S.; Elamin, F.M.; Fthenou, E.; Seed Ahmed, M.; Babu, G.R. Prenatal psychological distress and 11β-HSD2 gene expression in human placentas: Systematic review and meta-analysis. Psychoneuroendocrinology 2024, 166, 107060. [Google Scholar] [CrossRef]
  40. Müller, J.J.; Antonow-Schlorke, I.; Kroegel, N.; Rupprecht, S.; Rakers, F.; Witte, O.W.; Schwab, M. Cardiovascular effects of prenatal stress—Are there implications for cerebrovascular, cognitive and mental health outcome? Neurosci. Biobehav. Rev. 2020, 117, 78–97. [Google Scholar] [CrossRef]
  41. The Mathworks, Inc. Signal Processing Toolbox. 2024. Available online: https://la.mathworks.com/help/matlab/ref/ischange.html (accessed on 7 April 2025).
Figure 1. Normalized perfusion signals of a specific experimental subject. The normalized perfusion signals together with their PLAs, z t i and z ^ t i , t = 1 , , n i , given by Equation (7). The light gray subplot corresponds to the basal state (optimal TOI j = 1 ), the light blue to the cold state (optimal TOI j = 2 ), and the light red to the warm state (optimal TOI j = 3 ). Subject i = 9 of the control group (WT male, internal code WT14D4).
Figure 1. Normalized perfusion signals of a specific experimental subject. The normalized perfusion signals together with their PLAs, z t i and z ^ t i , t = 1 , , n i , given by Equation (7). The light gray subplot corresponds to the basal state (optimal TOI j = 1 ), the light blue to the cold state (optimal TOI j = 2 ), and the light red to the warm state (optimal TOI j = 3 ). Subject i = 9 of the control group (WT male, internal code WT14D4).
Bioengineering 12 00675 g001
Figure 2. Normalized perfusion signals of a specific experimental subject. The normalized perfusion signals together with their PLAs, z t i and z ^ t i , t = 1 , , n i , given by Equation (7). The same colors for the legends as in Figure 1 apply. Subject i = 17 of the experimental group (L-NAME female, internal code L7D3).
Figure 2. Normalized perfusion signals of a specific experimental subject. The normalized perfusion signals together with their PLAs, z t i and z ^ t i , t = 1 , , n i , given by Equation (7). The same colors for the legends as in Figure 1 apply. Subject i = 17 of the experimental group (L-NAME female, internal code L7D3).
Bioengineering 12 00675 g002
Figure 3. Box and whisker plots for WT and L-NAME perfusion signals. Non-normalized perfusion signal segment y t i , 1 t = 1 , , t i , 1 as defined by Equation (1) for optimal TOI j = 1 or basal state. See Appendix B.5 for an explanation of box and whisker plots.
Figure 3. Box and whisker plots for WT and L-NAME perfusion signals. Non-normalized perfusion signal segment y t i , 1 t = 1 , , t i , 1 as defined by Equation (1) for optimal TOI j = 1 or basal state. See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g003
Figure 4. Box and whisker plots for WT and L-NAME perfusion signals. Box and whisker plots of z t i , 1 in the basal state or TOI j = 1 computed according to Equation (3), of z t i , 2 z t i , 1 in Equation (4) for cold-to-basal differences, and of z t i , 3 z t i , 2 in Equation (4) for warm-to-cold differences. See Appendix B.5 for an explanation of box and whisker plots.
Figure 4. Box and whisker plots for WT and L-NAME perfusion signals. Box and whisker plots of z t i , 1 in the basal state or TOI j = 1 computed according to Equation (3), of z t i , 2 z t i , 1 in Equation (4) for cold-to-basal differences, and of z t i , 3 z t i , 2 in Equation (4) for warm-to-cold differences. See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g004
Figure 5. Box and whisker plots for WT and L-NAME cold-to-basal differences. Normalized perfusion signal differences z t i , 2 z t i , 1 for all i = 1 , , N , defined in Equation (4). See Appendix B.5 for an explanation of box and whisker plots.
Figure 5. Box and whisker plots for WT and L-NAME cold-to-basal differences. Normalized perfusion signal differences z t i , 2 z t i , 1 for all i = 1 , , N , defined in Equation (4). See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g005
Figure 6. Box and whisker plots for WT and L-NAME cold-to-basal differences. Normalized perfusion signal’s PLA differences z ^ t i , 2 z ^ t i , 1 for all i = 1 , , N , defined in Equation (4). See Appendix B.5 for an explanation of box and whisker plots.
Figure 6. Box and whisker plots for WT and L-NAME cold-to-basal differences. Normalized perfusion signal’s PLA differences z ^ t i , 2 z ^ t i , 1 for all i = 1 , , N , defined in Equation (4). See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g006
Figure 7. Box and whisker plots WT and L-NAME warm-to-cold differences. Perfusion signal differences z t i , 3 z t i , 2 for i = 1 , , N , normalized according to Equation (3). See Appendix B.5 for an explanation of box and whisker plots.
Figure 7. Box and whisker plots WT and L-NAME warm-to-cold differences. Perfusion signal differences z t i , 3 z t i , 2 for i = 1 , , N , normalized according to Equation (3). See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g007
Figure 8. Box and whisker plots WT and L-NAME warm-to-cold differences. PLA differences z ^ t i , 3 z ^ t i , 2 for i = 1 , N , normalized according to Equation (3). See Appendix B.5 for an explanation of box and whisker plots.
Figure 8. Box and whisker plots WT and L-NAME warm-to-cold differences. PLA differences z ^ t i , 3 z ^ t i , 2 for i = 1 , N , normalized according to Equation (3). See Appendix B.5 for an explanation of box and whisker plots.
Bioengineering 12 00675 g008
Table 1. Individual differences in response to the cold stimulus.
Table 1. Individual differences in response to the cold stimulus.
CodeGroup of InterestOverall DifferencesDifferences with WTDifferences with L-NAME
9WT14D4WT male32: 15 WT and 17 LNAMEAll othersAll
16WT16D5WT male32: 15 WT and 17 LNAMEAll othersAll
5WT15D3 1WT female31: 14 WT and 17 LNAMEAll others except №12All
12WT15D4 1WT male31: 14 WT and 17 LNAMEAll others except №5All
8WT14D1 2WT male29: 14 WT and 15 LNAMEAll others except №10All except №22 and №25
10WT14D5 2WT male29: 14 WT and 15 LNAMEAll others except №8All except №22 and №25
22L12D4 3LNAME female29: 14 WT and 15 LNAMEAll except №8 and №10All others except №25
25L13D4 3LNAME female29: 14 WT and 15 LNAMEAll except №8 and №10All others except №22
17L7D3LNAME female28: 12 WT and 15 LNAMEAll except №4, №6 and №7All others except №27
15WT16D4WT male2: 13 WT and 14 LNAMEAll others except №1 and №13All except №19, №28 and №33
1 Individuals responded similarly to the cool stimulus. 2 Individuals responded similarly to the cool stimulus. 3 Individuals responded similarly to the cool stimulus.
Table 2. Individual differences in response to the warm stimulus.
Table 2. Individual differences in response to the warm stimulus.
CodeGroup and SexOverall DifferencesDifference with WTDifference with L-NAME
5WT15D3WT female31: 14 WT and 17 L-NAMEAll others except №9All
15WT16D4WT male31: 14 WT and 17 L-NAMEAll others except №1All
9WT14D4WT male30: 13 WT and 17 L-NAMEAll others except №5 and №12All
19L11D2L-NAME female30: 15 WT and15 L-NAMEAll except №1All others except №25
8WT14D1 1WT male29: 12 WT and 17 L-NAMEAll except №4, №10 and №12All
10WT14D5 1WT male29: 12 WT and 17 L-NAMEAll except №4, №8, and №12All
12WT15D4WT male29: 12 WT and 17 L-NAMEAll except №8-10All
25L13D4L-NAME female28: 14 WT and 14 L-NAMEAll except №1 and №3All others except №19 and №29
11WT15D1WT male27: 13 WT and 14 L-NAMEAll others except №1 and №4All except №22, №24, and №26
1 Individuals responded similarly to the warm stimulus.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cumsille, P.; Troncoso, F.; Sandoval, H.; Acurio, J.; Escudero, C. A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms. Bioengineering 2025, 12, 675. https://doi.org/10.3390/bioengineering12060675

AMA Style

Cumsille P, Troncoso F, Sandoval H, Acurio J, Escudero C. A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms. Bioengineering. 2025; 12(6):675. https://doi.org/10.3390/bioengineering12060675

Chicago/Turabian Style

Cumsille, Patricio, Felipe Troncoso, Hermes Sandoval, Jesenia Acurio, and Carlos Escudero. 2025. "A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms" Bioengineering 12, no. 6: 675. https://doi.org/10.3390/bioengineering12060675

APA Style

Cumsille, P., Troncoso, F., Sandoval, H., Acurio, J., & Escudero, C. (2025). A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms. Bioengineering, 12(6), 675. https://doi.org/10.3390/bioengineering12060675

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop